A study of 182 type 1 diabetes patients revealed that 10% of those who had the disease for 31 to 40 years still produced C-peptides and showed intact beta-cell functioning, suggesting insulin production may continue for decades after the disease's onset. The findings in Diabetes Care suggest some patients with type 1 diabetes may benefit from treatments designed to preserve or enhance beta cell function, researchers said.
Insulin production may continue years after type 1 diabetes onset
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|